Purchase Order HHSN274201800003P

This is a firm fixed-price purchase order awarded by the Department of the Interior's Southeast Area to Novogene Corp Inc., a minority-owned small business. The $9,552.00 contract is for eukaryotic mRNA sequencing services, involving the preparation of 150 base pair paired-end libraries and the generation of 20 million raw reads per sample. The award does not have a set-aside designation. Novogene Corp Inc. is a provider of next-generation genomic sequencing and bioinformatics services,...

Genedx, LLC, a division of Opko Health, Inc., has been awarded a $25,000 firm fixed price purchase order by the National Institutes of Health's National Human Genome Research Institute to provide exome and genome sequencing with optional mitochondrial testing for various patients. The contract has a period of performance of just over one year, running from September 2023 through August 2024. Genedx will perform the sequencing and testing services at its laboratory location in Montgomery Village,...

This federal contract award, valued at $20,000.00, was issued by the National Human Genome Research Institute (NHGRI) to Genedx, LLC, a wholly owned subsidiary of Opko Health, Inc. The contract provides for the Genedx Hereditary MDS/Leukemia Panel (T830) and Copy Number Variation (CNV) testing services to be made available to potential participants who do not otherwise have access to this genetic testing. The contract is structured as a firm fixed-price purchase order with a period of...

Medgenome Inc. was awarded a $3,789.68 firm fixed price purchase order by the Department of the Interior's United States Geological Survey Office of Acquisitions and Grants. The contract calls for the delivery of HMW DNA extraction services to be performed in Foster City, California by September 23, 2021. As a small business, Medgenome Inc. has consistently provided genomic sequencing, laboratory testing, and DNA/RNA extraction services to federal agencies such as the Department of Health and...

This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Novogene Corp Inc., a minority-owned small business specializing in genomic sequencing and bioinformatics services. The $12,866.00 contract is for mRNA sequencing services to support NIAID's biomedical research efforts. Novogene has established itself as a key provider of DNA and RNA sequencing, library preparation, and data analysis services to various federal agencies,...

Medgenome Inc. was awarded a $9,115.50 firm fixed price purchase order by the United States Geological Survey (USGS), an agency of the Department of the Interior (DOI), to provide RNA extraction services. The contract has no set-aside designation and calls for the contractor to complete the extraction by September 19, 2021 at its place of performance in Foster City, California. Medgenome is a small for-profit organization that routinely provides genomic sequencing, laboratory testing, and...

This firm fixed-price purchase order was awarded by the Office of the Chief Operating Officer (a civilian agency), a component of the National Institutes of Health (NIH), to Genedx, LLC, a for-profit limited liability company. The $81,666 contract is for medical laboratory testing services, specifically genetic testing and diagnostic services. Genedx, a wholly owned subsidiary of Opko Health, Inc., provides comprehensive genetic testing, including mutation analysis, exome and genome...

This is a $26,650.70 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS) to Genewiz, LLC, a subsidiary of Azenta, Inc. The contract is for custom cloning and lentiviral preparation services to support the development of assays and therapeutics for NGYL1 disease within NCATS' Therapeutic Development Branch. The work includes gene cloning, lentiviral vector preparation, and generation of lentiviral particles at high titer. This contract has...

This is a firm fixed-price purchase order awarded by the Midwest Area civilian agency to Novogene Corp Inc., a minority-owned small business, for DNA sequencing services via the Illumina NovaSeq S4 platform. The $5,964 contract has a completion date of December 31, 2019 and does not utilize a set-aside designation. Novogene is a provider of next-generation sequencing and bioinformatics services, supporting various federal agencies with projects spanning biomedical, agricultural, environmental,...

This firm fixed-price purchase order, valued at $14,607.70, was awarded by the National Institute of Child Health and Human Development (NICHD) to Genscript USA Inc. for gene synthesis and cloning services. The ultimate completion date is August 29, 2024. Genscript is a biotechnology company based in Piscataway, New Jersey that specializes in molecular biology products and services to support biomedical research and public health initiatives for various federal agencies, including the National...